Seresto Dog Collar Under Fire For Alleged Cover-Up

The transcript discusses the controversy surrounding Seresto flea and tick collars, linked to 2500 dog deaths. Despite internal concerns from EPA staff, no action was taken to warn the public. The EPA allowed the product to remain on the market without additional warnings, unlike other countries. Internal emails reveal staff were discouraged from discussing the issue. The FDA was considered more reliable for regulation, but the EPA retained control. Alanko, the company behind Seresto, claims no unreasonable risk from the collars. The EPA's Inspector General is investigating the agency's response, while many dog owners demand a ban.

What did the FDA and EPA reportedly fail to do regarding the Seresto collars?

• They failed to approve the product.

• They failed to warn the public about the risks.

• They failed to manufacture the collars.

• They failed to sell the collars.

What was the reaction of EPA staff members to the Seresto collars?

• They ignored the product.

• They promoted the product.

• They supported the product.

• They voiced concerns about the product.

Why did EPA employees want to transfer regulation of Seresto to the FDA?

• The FDA had fewer regulations.

• The FDA had more funding.

• The FDA had a more comprehensive approval process.

• The FDA had better marketing strategies.

What is the stance of the company owning Seresto regarding the product's safety?

• They believe it poses an unreasonable risk.

• They claim it does not pose an unreasonable risk.

• They have admitted to the product's risks.

• They have not commented on the product's safety.

What action is being taken by the EPA's Office of Inspector General?

• They are promoting the product.

• They are banning the product worldwide.

• They are ignoring the issue.

• They are investigating the agency's response to concerns.